Targeting androgen receptor and PIP5K1A in prostate cancer cells using CRISPR-Cas9 genome editing tool
According to the World Cancer Research statistics, Prostate Cancer (PCa) accounts for 15% of all new cancer cases in men every year. More than 30% of treated patients will suffer disease recurrence and will develop Castration Resistant Prostate Cancer (CRPC), which no longer responds to androgen dep...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2017
|
| Online Access: | https://eprints.nottingham.ac.uk/39866/ |